Insulin glargine 300 U/ mL and insulin degludec: A review of the current evidence comparing these two second‐generation basal insulin analogues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Insulin glargine 300 U/ mL and insulin degludec: A review of the current evidence comparing these two second‐generation basal insulin analogues

Published:2020-06-11 Issue:7 Volume:36 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Cheng Alice¹^ORCID,Bailey Timothy S.²,Mauricio Didac³^ORCID,Roussel Ronan⁴⁵⁶

Affiliation:

1. Division of Endocrinology and Metabolism University of Toronto Toronto Ontario Canada

2. AMCR Institute Escondido California USA

3. Department of Endocrinology & Nutrition, CIBER of Diabetes and Associated Metabolic Diseases Hospital de la Santa Creu i Sant Pau Barcelona Spain

4. Diabetology Endocrinology Nutrition Hôpital Bichat, Assistance Publique Hôpitaux de Paris Paris France

5. INSERM, U‐1138 Centre de Recherche des Cordeliers Paris France

6. UFR de Médecine Paris University Paris France

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3329

Reference52 articles.

1. 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018

2. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018

3. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

4. Clinical Inertia in People With Type 2 Diabetes

5. Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Once-weekly Insulin Icodec as Compared to Once-daily Basal Insulins: A Meta-analysis;Endocrine Practice;2024-02

2. The economic value of insulin glargine 300 U/mL (Gla-300) in people ≥18 years of age with type 2 diabetes mellitus: a value-based economic model from a U.S. payer perspective;Journal of Medical Economics;2023-11-11

3. Use of IDegLira to Intensify, Simplify, and Increase Appropriateness of Type 2 Diabetes Therapy: A Real-Life Experience;Diabetes Therapy;2023-10-26

4. Cost‐effectiveness analysis of once‐daily insulin glargine 300 U/mL versus insulin degludec 100 U/mL using the BRAVO diabetes model;Diabetic Medicine;2023-05-12

5. Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial;Diabetes Research and Clinical Practice;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3